Rchr
J-GLOBAL ID:200901092598955514   Update date: Oct. 26, 2021

Kazama Hiromi

Kazama Hiromi
Research field  (1): Medical biochemistry
Research keywords  (3): 分子細胞生物学 ,  乳癌細胞 ,  Physiology of development(=generation) and growth Cell physiology
Research theme for competitive and other funds  (4):
  • 2020 - 2023 Targetting aggresome formation in metastatic breast cancer cells
  • 2016 - 2019 Novel therapeutic strategy in metastatic breast cancer by targeting misfolded protein-transport along microtubules and aggresome formation
  • 2016 - 2019 不良タンパク質の微小管輸送およびアグリソーム形成を標的とする転移性乳癌の新規治療
  • 2005 - 2006 ヒト味覚受容体遺伝子発現を利用した新規な味覚検査法の開発
Papers (28):
  • Masaya Miyazaki, Masaki Hiramoto, Naoharu Takano, Hiroko Kokuba, Jun Takemura, Mayumi Tokuhisa, Hirotsugu Hino, Hiromi Kazama, Keisuke Miyazawa. Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics. International journal of molecular medicine. 2021. 48. 4
  • Kazuhiro Hattori, Naoharu Takano, Hiromi Kazama, Shota Moriya, Keitaro Miyake, Masaki Hiramoto, Kiyoaki Tsukahara, Keisuke Miyazawa. Induction of synergistic non-apoptotic cell death by simultaneously targeting proteasomes with bortezomib and histone deacetylase 6 with ricolinostat in head and neck tumor cells. Oncology letters. 2021. 22. 3. 680-680
  • Kazutoshi Toriyama, Naoharu Takano, Hiroko Kokuba, Hiromi Kazama, Shota Moriya, Masaki Hiramoto, Shinji Abe, Keisuke Miyazawa. Azithromycin enhances the cytotoxicity of DNA-damaging drugs via lysosomal membrane permeabilization in lung cancer cells. Cancer science. 2021. 112. 8. 3324-3337
  • Kana Miyahara, Naoharu Takano, Yumiko Yamada, Hiromi Kazama, Mayumi Tokuhisa, Hirotsugu Hino, Koji Fujita, Edward Barroga, Masaki Hiramoto, Hiroshi Handa, et al. BRCA1 degradation in response to mitochondrial damage in breast cancer cells. Scientific reports. 2021. 11. 1. 8735-8735
  • Ayuka Yokota, Masaki Hiramoto, Hirotsugu Hino, Mayumi Tokuhisa, Masaya Miyazaki, Hiromi Kazama, Naoharu Takano, Keisuke Miyazawa. Sequestosome 1 (p62) accumulation in breast cancer cells suppresses progesterone receptor expression via argonaute 2. Biochemical and biophysical research communications. 2020. 531. 2. 256-263
more...
MISC (120):
Patents (1):
  • 新規な味覚物質受容体
Education (4):
  • - 2004 Nihon University
  • - 2004 Nihon University
  • - 2000 Nihon University
  • - 2000 Nihon University
Professional career (1):
  • 修士 (日本大学)
Work history (3):
  • 2015/04 - 現在 東京医科大学
  • 2000/09 - 2005/01 Nihon University School of Medicine
  • 2000 - - Assistant
Awards (1):
  • 2019/06 - 東京医科大学 佐々記念賞
Association Membership(s) (2):
THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page